<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Anticardiolipin antibodies (ACAs) of IgA, IgG, and IgM isotypes were measured using an enzyme-linked immunosorbent assay (ELISA) in patients with SLE, and in other groups of subjects with a higher or lower risk of developing <z:mp ids='MP_0005048'>thrombosis</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>IgA ACAs were present in high titers in <z:hpo ids='HP_0000001'>all</z:hpo> groups and had little discriminant value in predicting thrombotic risk </plain></SENT>
<SENT sid="2" pm="."><plain>In patients without the <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> (LAC) with conditions in which a thrombotic tendency was a feature (primigravidae with <z:e sem="disease" ids="C0032914" disease_type="Disease or Syndrome" abbrv="PEE|PREG1|PEE1">preeclampsia</z:e> or <z:hpo ids='HP_0001511'>intrauterine growth retardation</z:hpo>, patients with <z:mp ids='MP_0006112'>angina</z:mp> or <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo>, those on <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> therapy for apparently spontaneous <z:mp ids='MP_0005048'>thrombosis</z:mp>, and patients with <z:e sem="disease" ids="C0004943" disease_type="Disease or Syndrome" abbrv="">Behcet's syndrome</z:e> in whom there was a history of <z:mp ids='MP_0005048'>thrombosis</z:mp>) ACAs of <z:hpo ids='HP_0000001'>all</z:hpo> isotypes were present in 44/191 (23%) </plain></SENT>
<SENT sid="3" pm="."><plain>In patients in whom a thrombotic tendency was not a feature (<z:mpath ids='MPATH_458'>normal</z:mpath> controls, primigravidae with <z:mpath ids='MPATH_458'>normal</z:mpath> deliveries, patients with <z:hpo ids='HP_0001370'>rheumatoid arthritis</z:hpo>, and with <z:e sem="disease" ids="C0004943" disease_type="Disease or Syndrome" abbrv="">Behcet's syndrome</z:e> in whom there was no thrombotic history) 22/241 (9%) had ACAs </plain></SENT>
<SENT sid="4" pm="."><plain>Although ACAs were more likely to be present in a subset of patients without <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE) and/or the LAC, their presence was a poor discriminator of increased risk of <z:mp ids='MP_0005048'>thrombosis</z:mp> </plain></SENT>
</text></document>